This review begins with a discussion of the large family of Staphylococcus aureus and beta-
hemolytic streptococcal pyrogenic toxin T lymphocyte superantigens from structural and …

The global burden of disease caused by group A streptococcus (GAS) is not known. We
review recent population-based data to estimate the burden of GAS diseases and highlight …

Identify, treat, and manage the full range of skin diseases with guidance from Clinical
Dermatology: A Color Guide to Diagnosis and Therapy–the world's leading dermatology …

Group A streptococcus (GAS) or Streptococcus pyogenes has been recognised as an
important human pathogen since early days of modern microbiology, and it remains among …

▪ Abstract Toxic shock syndrome (TSS) is an acute onset illness characterized by fever, rash
formation, and hypotension that can lead to multiple organ failure and lethal shock, as well …

The efficacy and safety of high-dose intravenous polyspecific immunoglobulin G (IVIG) as
adjunctive therapy in streptococcal toxic shock syndrome (STSS) were evaluated in a …

PURPOSE: To determine the incidence of group A streptococcal necrotizing fasciitis in
Ontario, Canada, and to describe the clinical features, outcome, and microbiologic …

Background Several reports suggest that the incidence of invasive group A streptococcal
infections, including streptococcal toxic shock syndrome and necrotizing fasciitis, is …

Despite many synthetic biomaterials having physical properties that are comparable or even
superior to those of natural body tissues, they frequently fail due to the adverse physiological …

Twenty-one consecutive patients with streptococcal toxic shock syndrome (TSS) between
December 1994 and April 1995 were treated with a median dose of 2 g of intravenous …